August 18, 2026 – GLP-1 medications are reshaping food and beverage priorities across the US and Canada, pushing brands toward smaller, more nutrient-dense portions rather than simply “more food.” Consumers on these medications are shifting spend toward protein, fiber, hydration and gut-health support while cutting back on sugar, alcohol and low-nutrition categories, with grocery and supermarket channels becoming the key battleground. Since weight management is a long-term journey with people cycling on and off medication, brands need GLP-1-relevant (not GLP-1-exclusive) products that deliver everyday taste and nutritional value.
Talk to an expert for detailed forecasts and trend analyses for one of the world’s most innovative markets.
Interested in the Innova’s The GLP-1 Era: The Impact on Food, Ingredients & Innovation in the US & Canada report? Complete the contact form to purchase this report.
- Single Report: Purchase lifetime access to this specific study in PDF format
- Membership Access: Subscribe to our food and beverage market intelligence platform and access hundreds of reports and analytical tools.
